|
1.Landsteiner K, Levine P. Further observations on individual differences of human blood. Proc Soc Exp Biol Med, 1927. 24: p.941-2. 2.MatsonGA, Swanson J, Noades J. A ''new'' antigen and antibody belonging to the P blood group system. Am J Hum Genet. 1959, 11: 26–34. 3.Sanger R. An association between the P and Jay systems of blood groups. Nature, 1955. 176: p.1163-4. 4.Kortekangas AE, Kaarsalo E, Melartin L. The red cell antigen Pk and its relationship to the P system: The evidence of three more Pk families. Vox sang. 1965, 10: 385–404. 5.Iwamura K, Furukawa K, Uchikawa M, et al. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. J Biol Chem, 2003. 278: p.44429-38. 6.Lai Y.J., et al. A systematic study of single-nucleotide polymorphisms in the A4GALT gene suggests a molecular genetic basis for the P1/P2 blood groups. Transfusion, 2014. 54(12): p.3222-31. 7.Daniels G. Human blood groups. 3rd ed. Wiley-Blackwell, 2013. p. 162-164. 8.Iwamura K, Furukawa K, Uchikawa M, et al. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. J Biol Chem, 2003.278: p.44429-38. 9.Roback JD et al. AABB Technical Manual, 16th Ed. Bethesda: AABB Press, 2008 10.NCBI dbRBCP1PK Blood Group System. https://www.ncbi.nlm.nih.gov/projects/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=p 11.O. Delézay, D. Hammache, J. Fantini, N. Yahi. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry. 1996 Dec 10;35(49):15663-71. 12.Roback, JD, Combs, MR, Grossman, BJ & Hillyer, CD. (2008) AABB Technical Manual, 16th edn. 13.Helmuth L. Genome research: map of the human genome 3.0. Science, 2001. 293: p.583-585. 14.T. Okuda, N. Tokuda, S. Numata, M. Ito, M. Ohta, K. Kawamura, et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem, 2006 Apr 14;281(15):10230-5 15.R. Steffensen, K. Carlier, J. Wiels, S.B. Leveryi, M. Stroud, B. Cedergren, et al. Cloning and expression of the histo-blood group Pk UDP-galactose: Galβ1–4Glcβ1-Cer α1,4-galactosyltransferase. Molecular genetic basis of the p phenotype. BIOLOGICAL CHEMISTRY. June 2, pp. 16723–16729, 2000 16.B. Thuresson, J.S. Westman, M.L. Olsson. Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups. Blood, 117 (2011), pp. 678–687 17.Kandasamy Krishnaraju, Barbara Hoffman and Dan A. Liebermann. The Zinc Finger Transcription Factor Egr-1 Activates Macrophage Differentiation in M1 Myeloblastic Leukemia Cells, Blood 1998 92:1957-1966; 18.Tian J, Li Z, Han Y, Jiang T, Song X, Jiang G. The progress of early growth response factor 1 and leukemia. Intractable Rare Dis Res. 2016 May;5(2):76-82. 19.Fletcher KS, Bremer EG, Schwarting GA. P blood group regulation of glycosphingolipid levels in human erythrocytes. J Biol Chem, 1979. 254: p.11196-8. 20.Reynolds PR1, Cosio MG, Hoidal JR. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 2006 Sep;35(3):314-9. Epub 2006 Apr 6. 21.Zhaojun Xu, Roman Dziarski, Qiuling Wang,Kevin Swartz,Kathleen M. Sakamoto, and Dipika Gupta. Bacterial Peptidoglycan-Induced tnf-α Transcription Is Mediated Through the Transcription Factors Egr-1, Elk-1, and NF-κB. J Immunol 2001; 167:6975-6982 22.Lo LW, Cheng JJ, Chiu JJ, Wung BS, Liu YC, Wang DL. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway. J Cell Physiol. 2001 Sep;188(3):304-12. 23.Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med. 2000 Dec;6(12):1355-61. 24.J L Schwachtgen, P Houston, C Campbell, V Sukhatme, and M Braddock. Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. J Clin Invest. 1998 Jun 1; 101(11): 2540–2549. 25.DS Myung et al. Expression of Early Growth Response-1 in Colorectal Cancer and Its Relation to Tumor Cell Proliferation and Apoptosis. Oncol Rep. 2013 Nov 29 ;31 (2), 788-794. 26.Veyrac , Besnard , Caboche , Davis , Laroche. The transcription factor Zif268/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci. 2014 ;122:89-129. 27.Levon M. Khachigian. Early Growth Response-1 in Cardiovascular Pathobiology. Circulation Research. 2006 ;98:186-191 28.Abdulkadir SA. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.Ann N Y Acad Sci. 2005 Nov;1059:33-40. 29.Veronique Baron, Eileen D. Adamson, Antonella Calogero, Giuseppe Ragona, and Dan Mercola. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53 and fibronectin. Cancer Gene Ther. 2006 Feb; 13(2): 115–124. 30.Delphine Gitenay, Véronique T Baron. Is EGR1 a potential target for prostate cancer therapy? Future Oncol. 2009 Sep; 5(7): 993–1003. 31.Murali Gururajan,1 Alan Simmons, Trivikram Dasu, Brett T. Spear, Chris Calulot, Darrell A. Robertson, David L. Wiest, John G. Monroe, and Subbarao Bondada. Early growth response genes regulate B cell development, proliferation and immune response. J Immunol. 2008 Oct 1; 181(7): 4590–4602. 32.Gibbs JD1, Liebermann DA, Hoffman B. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia. Oncogene, 2008 Jan 3;27(1):98-106. 33.Sripichai O, Kiefer CM, Bhanu NV, Tanno T, Noh SJ, Goh SH, Russell JE, Rognerud CL, Ou CN, Oneal PA, Meier ER, Gantt NM, Byrnes C, Lee YT, Dean A, Miller JL. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood, 2009 Sep 10; 114(11): 2299–2306. 34.Benjamin L. Ebert. Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin Oncol. 2011 Oct; 38(5): 621–626. 35.J E Lancet1, A F List1 and L C Moscinski. Treatment of deletion 5q acute myeloid leukemia with lenalidomide. Leukemia, 2007 21, 586–588. 36.Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP. Allelic variation in gene expression is common in the human genome. Genome Res, 2003 Aug;13(8):1855-62. 37.Serre D, Gurd S, Ge B, Sladek R, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet, 2008. 4(2): p.e1000006. 38.Richard S Spielman, Laurel A Bastone, Joshua T Burdick, Michael Morley,Warren J Ewens, and Vivian G Cheung. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet, 2007 Feb; 39(2): 226–231. 39.Lomberg H, Jodal U, Eden CS, Leffler H, Samuelsson B. P1 blood group and urinary tract infection. Lancet, 1981 Mar 7;1(8219):551-2. 40.Keiko Furukawa, Keiko Yokoyama, Takeyuki Sato, Joelle Wiels, Yutaka Hirayama, Michio Ohta and Koichi Furukawa. Expression of the Gb3/CD77 Synthase Gene in Megakaryoblastic Leukemia Cells. BIOLOGICAL CHEMISTRY 2002 March 29 pp. 11247–11254 41.Harrison AL, Olsson ML, Jones RB, Ramkumar S, Sakac D, Binnington B, Henry S, Lingwood CA, Branch DR. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconj J, 2010 Jul;27(5):515-24. 42.Åsa Hellberg, Joyce Poole, and Martin L. Olsson. Molecular Basis of the Globoside-deficient Pk Blood Group Phenotype. BIOLOGICAL CHEMISTRY, 2002 August 16, pp. 29455–29459
|